Liver samples from FNA

PROCEDURE2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Chronic Hepatitis C

Phase 1

Evaluation of Hepatic Pharmacokinetics for Grazoprevir (MK-5172) in Participants With Chronic Hepatitis C (MK-5172-022)

WithdrawnNCT01547312

Merck Sharp & Dohme LLCChronic Hepatitis C

Start: 2012-05-31End: 2012-11-30Updated: 2015-10-14

Evaluating Fine Needle Aspiration to Measure Hepatic Vaniprevir (MK-7009) Concentrations in Participants With Chronic Hepatitis C (MK-7009-048)

CompletedNCT01678131

Merck Sharp & Dohme LLCChronic Hepatitis C

Start: 2012-10-30End: 2013-09-02Updated: 2022-08-26

Related Papers

Fine‐Needle Aspiration for the Evaluation of Hepatic Pharmacokinetics of Vaniprevir: A Randomized Trial in Patients With Hepatitis C Virus Infection

Clinical Pharmacology & Therapeutics2019-12-23